BEIJING, June 17 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported it will exhibit at the main Medicine Hall at the 2009 International Conference for Bioeconomy to be held from June 26 to June 28 in Tianjin, China.
About the 2009 International Conference for Bioeconomy-the 44th New Drugs Expo
The 2009 International Conference for Bioeconomy, sponsored by Ministry of Science and Technology, State Food and Drug Administration, and the Tianjin Municipal Government, is aimed to tackle financial crisis with the development of bio-economy. It provides a platform for marketing, networking, strategic partnership and information exchange. It is one of the largest and most reputable biotech and new drugs conferences in China. About 3,000 domestic and foreign companies are expected to be present at the exhibition. Eleven breakout sessions will be held to discuss frontier bio-technologies applied in life sciences, medicine, agriculture, energy, resources, environment and etc. For more information, please visit http://www.bioeco.net.cn .
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )
Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus's current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. More than 8,000 products are sold by Liang Fang directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces.
For more information, please contact: Lotus Pharmaceuticals, Inc. Yan Zeng, CFO Phone: +8610-6389-9868 Email: email@example.com Web: http://www.lotuspharma.com
|SOURCE Lotus Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved